Androgenic Alopecia Therapeutics Market 2027 by Therapy Type, Gender, Sales Channel, End User and Geography | The Insight Partners

Androgenic Alopecia Therapeutics Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Therapy Type (Medicines, Surgery and Other Therapies); Gender (Female and Male); Sales Channel (Over-the-Counter (OTC), and Prescription); End User (Hospitals, Dermatology Clinics and Home Care Settings) and Geography

Report Code: TIPRE00008560 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Androgenic alopecia is a genetic condition, which results into hair loss among both men and women. In the case of men, the hairline recedes, gradually leading to disappearance of hair from the crown and frontal scalp, whereas among women, a common thinning over the entire scalp with most extensive hair loss at the crown is witnessed. Some medical conditions leading to the occurrence of androgenic alopecia includes, enlargement or tumor in the prostate among men, coronary heart disease, diabetes and high blood pressure. Among women, the occurrence of androgenic alopecia is associated with polycystic ovary syndrome (PCOS).

MARKET DYNAMICS

The androgenic alopecia therapeutics market is anticipated to grow in the forecast, owing to rise in the cases of androgenic alopecia across the globe, coupled with change in lifestyle leading to baldness. Also, increased R&D expenditure for the development of innovative products are expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Androgenic Alopecia Therapeutics Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of androgenic alopecia therapeutics market with detailed market segmentation by therapy type, gender, sales channel, end user and geography. The androgenic alopecia therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading androgenic alopecia therapeutics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The androgenic alopecia therapeutics market is segmented based on therapy type, gender, sales channel, and end user. Based on therapy type the market is segmented as, medicines, surgery and other therapies. Based on gender the market is categorized as, female and male. Based on sales channel, the market is categorized as, over-the-counter (OTC) and prescription. Similarly, based on end user, the androgenic alopecia therapeutics market is classified as, hospitals, dermatology clinics and home care settings.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the androgenic alopecia therapeutics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The androgenic alopecia therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting androgenic alopecia therapeutics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the androgenic alopecia therapeutics market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the androgenic alopecia therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from androgenic alopecia therapeutics market are anticipated to have lucrative growth opportunities in the future with the rising demand for androgenic alopecia therapeutics market in the global market. Below mentioned is the list of few companies engaged in the androgenic alopecia therapeutics market.

The report also includes the profiles of key androgenic alopecia therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Almirall, S.A.
- BiologicsMD, Inc.
- Brickell Biotech, Inc.
- Cipla Inc.
- Concert Pharmaceuticals
- Dr. Reddy's Laboratories Ltd.
- HairClone Limited
- Merck & Co., Inc.
- RepliCel Life Sciences
- RiverTown Therapeutics Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Androgenic Alopecia Therapeutics Market - By Therapy Type
1.3.2 Androgenic Alopecia Therapeutics Market - By Gender
1.3.3 Androgenic Alopecia Therapeutics Market - By Sales Channel
1.3.4 Androgenic Alopecia Therapeutics Market - By End User
1.3.5 Androgenic Alopecia Therapeutics Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANDROGENIC ALOPECIA THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANDROGENIC ALOPECIA THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ANDROGENIC ALOPECIA THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANDROGENIC ALOPECIA THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. ANDROGENIC ALOPECIA THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ANDROGENIC ALOPECIA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - THERAPY TYPE
7.1. OVERVIEW
7.2. THERAPY TYPE MARKET FORECASTS AND ANALYSIS
7.3. MEDICINES
7.3.1. Overview
7.3.2. Medicines Market Forecast and Analysis
7.4. SURGERY
7.4.1. Overview
7.4.2. Surgery Market Forecast and Analysis
7.5. OTHER THERAPIES
7.5.1. Overview
7.5.2. Other Therapies Market Forecast and Analysis
8. ANDROGENIC ALOPECIA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - GENDER
8.1. OVERVIEW
8.2. GENDER MARKET FORECASTS AND ANALYSIS
8.3. FEMALE
8.3.1. Overview
8.3.2. Female Market Forecast and Analysis
8.4. MALE
8.4.1. Overview
8.4.2. Male Market Forecast and Analysis
9. ANDROGENIC ALOPECIA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - SALES CHANNEL
9.1. OVERVIEW
9.2. SALES CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. OVER-THE-COUNTER (OTC)
9.3.1. Overview
9.3.2. Over-the-Counter (OTC) Market Forecast and Analysis
9.4. PRESCRIPTION
9.4.1. Overview
9.4.2. Prescription Market Forecast and Analysis
10. ANDROGENIC ALOPECIA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS
10.3.1. Overview
10.3.2. Hospitals Market Forecast and Analysis
10.4. DERMATOLOGY CLINICS
10.4.1. Overview
10.4.2. Dermatology Clinics Market Forecast and Analysis
10.5. HOME CARE SETTINGS
10.5.1. Overview
10.5.2. Home Care Settings Market Forecast and Analysis
11. ANDROGENIC ALOPECIA THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Androgenic Alopecia Therapeutics Market Overview
11.1.2 North America Androgenic Alopecia Therapeutics Market Forecasts and Analysis
11.1.3 North America Androgenic Alopecia Therapeutics Market Forecasts and Analysis - By Therapy Type
11.1.4 North America Androgenic Alopecia Therapeutics Market Forecasts and Analysis - By Gender
11.1.5 North America Androgenic Alopecia Therapeutics Market Forecasts and Analysis - By Sales Channel
11.1.6 North America Androgenic Alopecia Therapeutics Market Forecasts and Analysis - By End User
11.1.7 North America Androgenic Alopecia Therapeutics Market Forecasts and Analysis - By Countries
11.1.7.1 United States Androgenic Alopecia Therapeutics Market
11.1.7.1.1 United States Androgenic Alopecia Therapeutics Market by Therapy Type
11.1.7.1.2 United States Androgenic Alopecia Therapeutics Market by Gender
11.1.7.1.3 United States Androgenic Alopecia Therapeutics Market by Sales Channel
11.1.7.1.4 United States Androgenic Alopecia Therapeutics Market by End User
11.1.7.2 Canada Androgenic Alopecia Therapeutics Market
11.1.7.2.1 Canada Androgenic Alopecia Therapeutics Market by Therapy Type
11.1.7.2.2 Canada Androgenic Alopecia Therapeutics Market by Gender
11.1.7.2.3 Canada Androgenic Alopecia Therapeutics Market by Sales Channel
11.1.7.2.4 Canada Androgenic Alopecia Therapeutics Market by End User
11.1.7.3 Mexico Androgenic Alopecia Therapeutics Market
11.1.7.3.1 Mexico Androgenic Alopecia Therapeutics Market by Therapy Type
11.1.7.3.2 Mexico Androgenic Alopecia Therapeutics Market by Gender
11.1.7.3.3 Mexico Androgenic Alopecia Therapeutics Market by Sales Channel
11.1.7.3.4 Mexico Androgenic Alopecia Therapeutics Market by End User
11.2. EUROPE
11.2.1 Europe Androgenic Alopecia Therapeutics Market Overview
11.2.2 Europe Androgenic Alopecia Therapeutics Market Forecasts and Analysis
11.2.3 Europe Androgenic Alopecia Therapeutics Market Forecasts and Analysis - By Therapy Type
11.2.4 Europe Androgenic Alopecia Therapeutics Market Forecasts and Analysis - By Gender
11.2.5 Europe Androgenic Alopecia Therapeutics Market Forecasts and Analysis - By Sales Channel
11.2.6 Europe Androgenic Alopecia Therapeutics Market Forecasts and Analysis - By End User
11.2.7 Europe Androgenic Alopecia Therapeutics Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Androgenic Alopecia Therapeutics Market
11.2.7.1.1 Germany Androgenic Alopecia Therapeutics Market by Therapy Type
11.2.7.1.2 Germany Androgenic Alopecia Therapeutics Market by Gender
11.2.7.1.3 Germany Androgenic Alopecia Therapeutics Market by Sales Channel
11.2.7.1.4 Germany Androgenic Alopecia Therapeutics Market by End User
11.2.7.2 France Androgenic Alopecia Therapeutics Market
11.2.7.2.1 France Androgenic Alopecia Therapeutics Market by Therapy Type
11.2.7.2.2 France Androgenic Alopecia Therapeutics Market by Gender
11.2.7.2.3 France Androgenic Alopecia Therapeutics Market by Sales Channel
11.2.7.2.4 France Androgenic Alopecia Therapeutics Market by End User
11.2.7.3 Italy Androgenic Alopecia Therapeutics Market
11.2.7.3.1 Italy Androgenic Alopecia Therapeutics Market by Therapy Type
11.2.7.3.2 Italy Androgenic Alopecia Therapeutics Market by Gender
11.2.7.3.3 Italy Androgenic Alopecia Therapeutics Market by Sales Channel
11.2.7.3.4 Italy Androgenic Alopecia Therapeutics Market by End User
11.2.7.4 Spain Androgenic Alopecia Therapeutics Market
11.2.7.4.1 Spain Androgenic Alopecia Therapeutics Market by Therapy Type
11.2.7.4.2 Spain Androgenic Alopecia Therapeutics Market by Gender
11.2.7.4.3 Spain Androgenic Alopecia Therapeutics Market by Sales Channel
11.2.7.4.4 Spain Androgenic Alopecia Therapeutics Market by End User
11.2.7.5 United Kingdom Androgenic Alopecia Therapeutics Market
11.2.7.5.1 United Kingdom Androgenic Alopecia Therapeutics Market by Therapy Type
11.2.7.5.2 United Kingdom Androgenic Alopecia Therapeutics Market by Gender
11.2.7.5.3 United Kingdom Androgenic Alopecia Therapeutics Market by Sales Channel
11.2.7.5.4 United Kingdom Androgenic Alopecia Therapeutics Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Androgenic Alopecia Therapeutics Market Overview
11.3.2 Asia-Pacific Androgenic Alopecia Therapeutics Market Forecasts and Analysis
11.3.3 Asia-Pacific Androgenic Alopecia Therapeutics Market Forecasts and Analysis - By Therapy Type
11.3.4 Asia-Pacific Androgenic Alopecia Therapeutics Market Forecasts and Analysis - By Gender
11.3.5 Asia-Pacific Androgenic Alopecia Therapeutics Market Forecasts and Analysis - By Sales Channel
11.3.6 Asia-Pacific Androgenic Alopecia Therapeutics Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Androgenic Alopecia Therapeutics Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Androgenic Alopecia Therapeutics Market
11.3.7.1.1 Australia Androgenic Alopecia Therapeutics Market by Therapy Type
11.3.7.1.2 Australia Androgenic Alopecia Therapeutics Market by Gender
11.3.7.1.3 Australia Androgenic Alopecia Therapeutics Market by Sales Channel
11.3.7.1.4 Australia Androgenic Alopecia Therapeutics Market by End User
11.3.7.2 China Androgenic Alopecia Therapeutics Market
11.3.7.2.1 China Androgenic Alopecia Therapeutics Market by Therapy Type
11.3.7.2.2 China Androgenic Alopecia Therapeutics Market by Gender
11.3.7.2.3 China Androgenic Alopecia Therapeutics Market by Sales Channel
11.3.7.2.4 China Androgenic Alopecia Therapeutics Market by End User
11.3.7.3 India Androgenic Alopecia Therapeutics Market
11.3.7.3.1 India Androgenic Alopecia Therapeutics Market by Therapy Type
11.3.7.3.2 India Androgenic Alopecia Therapeutics Market by Gender
11.3.7.3.3 India Androgenic Alopecia Therapeutics Market by Sales Channel
11.3.7.3.4 India Androgenic Alopecia Therapeutics Market by End User
11.3.7.4 Japan Androgenic Alopecia Therapeutics Market
11.3.7.4.1 Japan Androgenic Alopecia Therapeutics Market by Therapy Type
11.3.7.4.2 Japan Androgenic Alopecia Therapeutics Market by Gender
11.3.7.4.3 Japan Androgenic Alopecia Therapeutics Market by Sales Channel
11.3.7.4.4 Japan Androgenic Alopecia Therapeutics Market by End User
11.3.7.5 South Korea Androgenic Alopecia Therapeutics Market
11.3.7.5.1 South Korea Androgenic Alopecia Therapeutics Market by Therapy Type
11.3.7.5.2 South Korea Androgenic Alopecia Therapeutics Market by Gender
11.3.7.5.3 South Korea Androgenic Alopecia Therapeutics Market by Sales Channel
11.3.7.5.4 South Korea Androgenic Alopecia Therapeutics Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Androgenic Alopecia Therapeutics Market Overview
11.4.2 Middle East and Africa Androgenic Alopecia Therapeutics Market Forecasts and Analysis
11.4.3 Middle East and Africa Androgenic Alopecia Therapeutics Market Forecasts and Analysis - By Therapy Type
11.4.4 Middle East and Africa Androgenic Alopecia Therapeutics Market Forecasts and Analysis - By Gender
11.4.5 Middle East and Africa Androgenic Alopecia Therapeutics Market Forecasts and Analysis - By Sales Channel
11.4.6 Middle East and Africa Androgenic Alopecia Therapeutics Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Androgenic Alopecia Therapeutics Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Androgenic Alopecia Therapeutics Market
11.4.7.1.1 South Africa Androgenic Alopecia Therapeutics Market by Therapy Type
11.4.7.1.2 South Africa Androgenic Alopecia Therapeutics Market by Gender
11.4.7.1.3 South Africa Androgenic Alopecia Therapeutics Market by Sales Channel
11.4.7.1.4 South Africa Androgenic Alopecia Therapeutics Market by End User
11.4.7.2 Saudi Arabia Androgenic Alopecia Therapeutics Market
11.4.7.2.1 Saudi Arabia Androgenic Alopecia Therapeutics Market by Therapy Type
11.4.7.2.2 Saudi Arabia Androgenic Alopecia Therapeutics Market by Gender
11.4.7.2.3 Saudi Arabia Androgenic Alopecia Therapeutics Market by Sales Channel
11.4.7.2.4 Saudi Arabia Androgenic Alopecia Therapeutics Market by End User
11.4.7.3 U.A.E Androgenic Alopecia Therapeutics Market
11.4.7.3.1 U.A.E Androgenic Alopecia Therapeutics Market by Therapy Type
11.4.7.3.2 U.A.E Androgenic Alopecia Therapeutics Market by Gender
11.4.7.3.3 U.A.E Androgenic Alopecia Therapeutics Market by Sales Channel
11.4.7.3.4 U.A.E Androgenic Alopecia Therapeutics Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Androgenic Alopecia Therapeutics Market Overview
11.5.2 South and Central America Androgenic Alopecia Therapeutics Market Forecasts and Analysis
11.5.3 South and Central America Androgenic Alopecia Therapeutics Market Forecasts and Analysis - By Therapy Type
11.5.4 South and Central America Androgenic Alopecia Therapeutics Market Forecasts and Analysis - By Gender
11.5.5 South and Central America Androgenic Alopecia Therapeutics Market Forecasts and Analysis - By Sales Channel
11.5.6 South and Central America Androgenic Alopecia Therapeutics Market Forecasts and Analysis - By End User
11.5.7 South and Central America Androgenic Alopecia Therapeutics Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Androgenic Alopecia Therapeutics Market
11.5.7.1.1 Brazil Androgenic Alopecia Therapeutics Market by Therapy Type
11.5.7.1.2 Brazil Androgenic Alopecia Therapeutics Market by Gender
11.5.7.1.3 Brazil Androgenic Alopecia Therapeutics Market by Sales Channel
11.5.7.1.4 Brazil Androgenic Alopecia Therapeutics Market by End User
11.5.7.2 Argentina Androgenic Alopecia Therapeutics Market
11.5.7.2.1 Argentina Androgenic Alopecia Therapeutics Market by Therapy Type
11.5.7.2.2 Argentina Androgenic Alopecia Therapeutics Market by Gender
11.5.7.2.3 Argentina Androgenic Alopecia Therapeutics Market by Sales Channel
11.5.7.2.4 Argentina Androgenic Alopecia Therapeutics Market by End User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. ANDROGENIC ALOPECIA THERAPEUTICS MARKET, KEY COMPANY PROFILES
13.1. ALMIRALL, S.A.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BIOLOGICSMD, INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BRICKELL BIOTECH, INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. CIPLA INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. CONCERT PHARMACEUTICALS
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. DR. REDDY’S LABORATORIES LTD.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. HAIRCLONE LIMITED
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. MERCK & CO., INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. REPLICEL LIFE SCIENCES
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. RIVERTOWN THERAPEUTICS INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Almirall, S.A.
2. BiologicsMD, Inc.
3. Brickell Biotech, Inc.
4. Cipla Inc.
5. Concert Pharmaceuticals
6. Dr. Reddy's Laboratories Ltd.
7. HairClone Limited
8. Merck & Co., Inc.
9. RepliCel Life Sciences
10. RiverTown Therapeutics Inc.
TIPRE00008560
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking